Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US

Li Nanxin; Hao Yanni; Kageleiry Andrew; Peeples Miranda; Fang Anna; Koo Valerie; Wu Eric Q.; Guerin Annie

首页> 外文期刊>Current medical research and opinion >Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US

【24h】

Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US

机译：激素受体阳性/人表皮生长因子受体-2-阴性转移性乳腺癌绝经后妇女治疗依维莫司和化学疗法的时间：在美国的一项回顾性研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective:

机译：目的：

著录项

来源
《Current medical research and opinion》 |2016年第2期|共10页
作者
Li Nanxin; Hao Yanni; Kageleiry Andrew; Peeples Miranda; Fang Anna; Koo Valerie; Wu Eric Q.; Guerin Annie;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Capecitabine; Chemotherapy; Everolimus; HR+/HER2-metastatic breast cancer; Time on treatment;

机译：卡培他滨;化学疗法;依维莫司;HR + / HER2转移性乳腺癌;治疗时间;

相似文献

外文文献
中文文献
专利

1. Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US [J] . Li Nanxin, Hao Yanni, Kageleiry Andrew, Current medical research and opinion . 2016,第2期

机译：激素受体阳性/人表皮生长因子受体-2-阴性转移性乳腺癌绝经后妇女治疗依维莫司和化学疗法的时间：在美国的一项回顾性研究
2. RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS [J] . Vanacker Leen The Breast : . 2015,第Suppla3期

机译：芳香胺抑制剂和选择性雌激素修饰的激素受体阳性转移性乳腺癌的绝经后妇女中雌花不齐的回顾性研究
3. RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS [J] . Vanacker Leen The Breast : . 2015,第Suppla3期

机译：用芳香糖酶抑制剂（AI's）和选择性雌激素改性剂预处理促血管蛋白酶阳性转移性乳腺癌前代妇女血尿血症血尿症的回顾性研究
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. Investigating age varying effect of access to cancer care on immediate choice of chemotherapy among elderly women with metastatic breast cancer. [D] . Wan, Shaowei. 2010

机译：调查在转移性乳腺癌的老年妇女中，癌症治疗对立即选择化疗的年龄差异影响。
6. A randomized double-blind controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer [O] . Hiroji Iwata, Norikazu Masuda, Shinji Ohno, -1

机译：依西美坦与阿那曲唑的随机双盲对照研究用于绝经后日本女性激素受体阳性晚期乳腺癌的一线治疗
7. A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer [O] . 2013

机译：依西美坦与阿那曲唑的随机，双盲对照研究，用于绝经后日本女性激素受体阳性晚期乳腺癌的一线治疗

Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅